1+ hour, 29+ min ago  (136+ words) Pharma Dispatch Cartherics and Catalent deepen partnership to accelerate next generation cell therapies Cartherics and Catalent have strengthened their collaboration to accelerate the development and future commercialisation of advanced immune cell therapies. " Sanofi's Liz Selby - 'We don't lack ideas, but…...

3+ week, 1+ day ago  (156+ words) Pharma Dispatch Australia stakes a claim in global gene therapy manufacturing through new partnership In a move that signals growing momentum for Australia's role in advanced therapeutics, Viral Vector Manufacturing Facility has entered into a licensing agreement with global cell…...

3+ week, 2+ day ago  (162+ words) Pharma Dispatch Renewed calls for major investment in life sciences to secure nation's innovation future Medicines Australia and Aus Biotech have endorsed the release of the 'Ambitious Australia: Strategic Examination of R&D Final Report', describing it as a significant…...

1+ mon, 1+ day ago  (133+ words) Pharma Dispatch Lateral Pharma secures key U. S. patent for novel neuropathic pain therapy Lateral Pharma has secured a significant intellectual property milestone with the granting of a U. S. composition-of-matter patent for LAT9997, the company's next-generation therapeutic candidate targeting the Lan CL pathway for…...

1+ mon, 1+ day ago  (242+ words) Pharma Dispatch Nanosonics achieves key FDA clearance as CORIS Endoscope coverage expands Nanosonics (ASX: NAN) has reached an important regulatory milestone after the United States Food and Drug Administration granted 510(k) clearance that broadens the range of endoscopes compatible with the…...

1+ mon, 5+ day ago  (171+ words) Pharma Dispatch A system built for a past is struggling to meet the challenge of today, let alone the future While it is understandable that companies will prioritise large and potentially lucrative markets, surely the correct response from smaller or…...